1987
DOI: 10.1007/bf01913355
|View full text |Cite
|
Sign up to set email alerts
|

Sur le Polymorphisme du barbital et le systeme eau-barbital

Abstract: The crystal structures of three forms (I, II and IV) of barbital are well known. The DTA curve of barbital 1 is marked by only one endotherm, at 186 ~ which is the melting point of this crystalline form. For barbital II, the DTA curve shows a first endotherm at 160 ~ which indicates the transition point II ~ I, and then an endotherm at 186 ~ for the melting of form I. By fast cooling of a boiling saturated aqueous solution, another crystalline form of barbital (form X) can be obtained. The DTA curve of this ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

1988
1988
2013
2013

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 9 publications
0
1
0
1
Order By: Relevance
“…Surprisingly, to the best of our knowledge, the ability of lidocaine to form “nonconventional” emulsions has never been related to the formation of miscibility gaps, that can easily be evidenced by visual observation of how lidocaine–water mixtures behave on heating in screw‐cap tubes. Miscibility gaps have already been observed in other drug–water systems (systems barbital–water16 and phenobarbital–water,17 for instance). Nevertheless, up to what extend such miscibility gaps form in drug–water systems remains to be assessed through systematic investigations.…”
Section: Discussionmentioning
confidence: 90%
“…Surprisingly, to the best of our knowledge, the ability of lidocaine to form “nonconventional” emulsions has never been related to the formation of miscibility gaps, that can easily be evidenced by visual observation of how lidocaine–water mixtures behave on heating in screw‐cap tubes. Miscibility gaps have already been observed in other drug–water systems (systems barbital–water16 and phenobarbital–water,17 for instance). Nevertheless, up to what extend such miscibility gaps form in drug–water systems remains to be assessed through systematic investigations.…”
Section: Discussionmentioning
confidence: 90%
“…Nous avons vu dans un pr6c6dent article [1] que l'hydrate du barbital n'6tait pas connu et qu'il n'avait pu &re mis en 6vidence par l'&ude polythermique h volume constant du systbme eau-barbital. En revanche, l'hydrate du ph6nobarbital a &6 d~crit ; il poss~de une fusion incongruente et Sa structure cristalline est r6solue [2].…”
unclassified